EDEmmanuel Sánchez Díaz

Emmanuel Sánchez Díaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emmanuel Sánchez Díaz has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions

    by René Pareja, Fernando Heredia, Emmanuel Sánchez-Díaz, Mauricio A. Cuello, Silvia de Sanjosé, José Jerónimo, Suzanne M. Garland, Marta del Pino, Angélica Fletcher, Aureli Torné, et al.

  • Open Access

    FIGO / IGCS statement on the efficacy of topical treatments for high‐risk human papillomavirus in preventing CIN 3+ lesions

    by René Pareja, Fernando Heredia, Emmanuel Sánchez‐Díaz, Mauricio A. Cuello, Silvia de Sanjosé, José Jerónimo, Suzanne M. Garland, Marta del Pino, Angélica Fletcher, Aureli Torné, et al.

    Cervical cancer is caused by persistent high‐risk human papillomavirus (HR‐HPV) infection and remains a major global health burden despite available preventive strategies. Most HR‐HPV infections and associated low‐grade squamous intraepithelial lesions (LSIL) regress spontaneously, yet increasing commercial promotion of topical therapies targeting HPV clearance has emerged in clinical practice. This FIGO/International Gynecologic Cancer Society (IGCS) Position Statement critically appraises the available evidence on topical treatments for HR‐HPV infection and LSIL, and provides evidence‐based recommendations for clinical practice and future research. No randomized controlled trial has been adequately designed or powered to evaluate the effect of topical therapies on the prevention of histologically confirmed high‐grade squamous intraepithelial lesions (HSIL/CIN3+). Available studies are characterized by small sample sizes, short follow‐up periods, heterogeneous populations, inadequate comparators, and reliance on surrogate endpoints of uncertain clinical relevance, including cytological regression, HPV nondetection, and immunohistochemical markers such as p16/Ki‐67. Published meta‐analyses reporting statistically significant improvements in virological and cytological surrogates are limited by substantial heterogeneity, publication bias, and follow‐up periods under 1 year. Product‐specific appraisal of Coriolus versicolor‐based and silicon dioxide/selenite‐based vaginal gels reveal additional methodological concerns, including retrospective trial registration, industry funding, and misinterpretation of findings consistent with the spin phenomenon. In the absence of high‐quality evidence demonstrating clinically meaningful benefit, FIGO and IGCS do not endorse the routine clinical use of any currently available topical agent for HR‐HPV infection or LSIL. Evidence‐based surveillance remains the standard of care. Future research should prioritize rigorous trial design with histologically confirmed HSIL/CIN3+ as the primary endpoint, adequate follow‐up of at least 3 years, and appropriate comparators. Clinical management should center on informed shared decision‐making and evidence‐based counseling, rather than on interventions lacking proven clinical benefit.

  • Clinical and pathological outcomes of brachytherapy application for the treatment of high-grade vaginal squamous intraepithelial lesions: a systematic review

    by Carlos Felipe Durán Méndez, Juan Carlos Mendieta Redondo, Juan Sebastián Obando Rodríguez, Emmanuel Sánchez Díaz, Jonathan Peralta-Jiménez, Santiago Vieira-Serna, Carolina Morante-Caicedo, Núria Agustí, Santiago Ardila Giraldo, John Edwin Feliciano-Alfonso, et al.

  • Open Access

    Citorreducción de Intervalo y Paniculectomía Abdominal en Flor de Lis en Carcinosarcoma Endometrial Avanzado Asociado a Obesidad Mórbida Extrema: Reporte de Caso y Revisión de la Literatura

    by Juan Carlos Mendieta Redondo, Emmanuel Sanchez Diaz, Juan Sebastian Obando Rodriguez, Carlos Felipe Duran Mendez

    El carcinosarcoma uterino es una neoplasia endometrial infrecuente, agresiva y de alto riesgo, asociada con diseminación extrauterina y elevada probabilidad de recurrencia. Presentamos el caso de una paciente de 68 años con obesidad mórbida extrema (peso 111 kg, talla 1,52 m; IMC 48,0 kg/m²), con diagnóstico inicial de carcinoma seroso de alto grado de endometrio, en quien se intentó cirugía primaria por abordaje robótico, la cual no pudo completarse por implantes peritoneales, adherencias firmes y bloque tumoral pélvico, además de limitación técnica por panículo abdominal masivo. Posteriormente recibió quimioterapia neoadyuvante con carboplatino/paclitaxel (4 ciclos) y fue revalorada en junta multidisciplinaria, decidiéndo citorreducción de intervalo con abordaje conjunto de ginecología oncológica y cirugía plástica. El procedimiento definitivo incluyó paniculectomía abdominal en flor de lis (colgajo resecado de 12.100 g), seguida de histerectomía abdominal total, salpingo-ooforectomía bilateral, omentectomía parcial y resección de implante de pared abdominal. En el posoperatorio presentó seromas de pared abdominal que requirieron drenaje percutáneo, sin otras complicaciones mayores. La patología definitiva confirmó carcinosarcoma uterino con elementos heterólogos tipo rabdomiosarcoma, invasión miometrial profunda (17/20 mm, ~85%), invasión linfovascular y compromiso extrauterino, con afectación de omento e implante de pared abdominal; inmunohistoquímica con p53 aberrante, receptores hormonales negativos y MMR intacto. Se definió completar 3 ciclos adyuvantes de carboplatino/paclitaxel. Este caso resalta el valor del manejo individualizado y multidisciplinario en enfermedad uterina avanzada con barreras anatómicas extremas, y el papel de la paniculectomía funcional para facilitar una citorreducción segura y adecuada.

  • Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic review

    by Rene Pareja, Núria Agustí, Santiago Vieira, Nathalia Mora-Soto, Emmanuel Sanchez, Andreína Fernandes, Beatriz Aristizábal, Fernando Heredia, Gabriel Levin, Melissa Lopez Varon, et al.


  • Colposcopists' practice patterns in Latin America: An international cross‐sectional survey

    by Carlos Arturo Buitrago‐Duque, Ricardo Buitrago Bach, Laura Fleider, Emmanuel Sánchez‐Díaz

    Cervical cancer is a public health issue worldwide. Colposcopy is a key tool in the early diagnosis of preinvasive disease. Its practice is heterogeneous due to variations in its performance and the training of professionals. This study aimed to describe colposcopy practice patterns among Latin American gynecologists. A web survey was conducted among colposcopists. A 60‐item questionnaire was designed and piloted with 40 physicians. The survey was conducted online voluntarily through a link that was sent to 2217 gynecologist members of the Latin American Federation of Lower Genital Tract Pathology and Colposcopy (FLPTGIC) between April 2024 and January 2025. The survey was answered by 787 colposcopists, with a response rate of 35.49%. The majority were from Mexico (17.92%); 60.61% were women between 30 and 50 years of age. Almost all practitioners (98.68%) performed cervical assessments after applying acetic acid, and 49.94% used Lugol's iodine routinely. More than 90% examined the vulva, and 68.74% examined the vagina during colposcopy. Fewer than half of the participants always reported the colposcopic diagnosis according to the Rio 2011 Colposcopy Nomenclature, and three‐quarters reported whether the squamocolumnar junction was visible. More than one‐third (37.48%) followed the American Society of Colposcopy and Cervical Pathology guidelines, and 3.2% used International Federation for Cancer Prevention and Colposcopy terminology. When diagnosing dysplasia, more than 90% performed resective methods (91.74%), and colposcopy is the main follow‐up strategy. There is a high degree of heterogeneity in training, colposcopic practice patterns, and therapeutic decisions in cases of preinvasive disease among Latin American professionals, even though several scientific associations have established standards and guidelines.


  • Silicon dioxide, sodium selenite and citric acid vaginal gel, HPV infection, and cervical preinvasive disease: a narrative review

    by Emmanuel Sánchez Díaz, Gabriel Levin, Beatriz Aristizabal, Andreína Fernandes, Florencia Noll, David Cantú, Fernando Heredia, Helena M. Obermair, Rene Pareja


  • Development and implementation of a novel metric score (SciMet) for scientific publications

    by Emmanuel Sánchez‐Díaz, David Viveros‐Carreño, Gabriel Levin, Pedro T. Ramírez, René Pareja

    There is no formal or standard measure of quality, clinical impact, and scientific merit in the current literature in gynecologic oncology besides formal citation metrics. We aimed to develop and implement a multiparametric score to identify influential articles with transformative impact in gynecology oncology. We conducted a systematic search using PubMed from January 2010 to December 2022 for gynecologic oncology publications. Publications were ranked based on citations per year, top 100 were selected. After excluding 17, 83 original articles were included. A multiparametric score (SciMet) was developed to assess its relevance and impact considering citations per year, journal impact factor, study design, sample size, and altmetric attention score; numeric scores were assigned based on quartiles. This scoring system was applied to articles with citations per year values above the median (39 articles). Thirty‐nine studies were analyzed based on the score. Number of CPY ranged from 42.7 to 261.2; journal IF, from 17.76 to 202.7; and sample size from 20 to 1 672 983. The total SciMet score ranged from 17 to 47 (median of 34). The top 10 included studies addressed screening interventions for ovarian cancer, PARP inhibitors and bevacizumab use as first‐line maintenance in ovarian cancer, surgical trials in cervical cancer, and HPV vaccination impact on cervical intraepithelial neoplasia or cancer development. Articles with higher scores were mostly randomized clinical trials, and besides having high metrics, led to changes in management of gynecologic cancers, resulting in their incorporation into guidelines that shape established norms in the field.

  • Open Access

    Recurrent leiomyomatosis peritonealis disseminata

    by Emmanuel Sanchez Diaz, Gabriel Jaime Rendon Pereira, Rene Pareja, Oscar German Palacios Rodriguez, Carlos Andres Serna Ortíz, Claudia Patricia Huertas Duran

    Subsequently, surveillance MRI in July 2018 showed free fluid in the pelvis, peritoneal implants, a 5×3 cm mass in the cul-de-sac, and uterine myomatosis. At that time, she underwent laparoscopy where gross findings included a left ovarian tumor with a coralliform appearance of approximately 5 cm, omentum adhesion to the previous myomectomy bed and to the pelvic peritoneum, normal right ovary, uterus with a right intraligamentary myoma extending through the right pillar of the bladder without other lesions, free fluid in the pelvis, tumor implant in the omentum, right diaphragmatic dome and a mirror lesion in the liver.